These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 9525433)
1. Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects. Stafford MK; Ward H; Flanagan A; Rosenstein IJ; Taylor-Robinson D; Smith JR; Weber J; Kitchen VS J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(4):327-31. PubMed ID: 9525433 [TBL] [Abstract][Full Text] [Related]
2. Nonoxynol-9 in lubricated condoms. Results of a study in female prostitutes. Ward H; De La Court A; Kitchen V Sex Transm Dis; 1996; 23(5):413-4. PubMed ID: 8885074 [TBL] [Abstract][Full Text] [Related]
3. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases. Roddy RE; Zekeng L; Ryan KA; Tamoufé U; Weir SS; Wong EL N Engl J Med; 1998 Aug; 339(8):504-10. PubMed ID: 9709043 [TBL] [Abstract][Full Text] [Related]
4. A phase I comparative study of three contraceptive vaginal films containing nonoxynol-9. Postcoital testing and colposcopy. Mauck CK; Baker JM; Barr SP; Johanson WM; Archer DF Contraception; 1997 Aug; 56(2):97-102. PubMed ID: 9315418 [TBL] [Abstract][Full Text] [Related]
5. Safety of a nonoxynol-9 vaginal gel in Kenyan prostitutes. A randomized clinical trial. Martin HL; Stevens CE; Richardson BA; Rugamba D; Nyange PM; Mandaliya K; Ndinya-Achola J; Kreiss JK Sex Transm Dis; 1997 May; 24(5):279-83. PubMed ID: 9153737 [TBL] [Abstract][Full Text] [Related]
6. Study of the vaginal tolerance to Acidform, an acid-buffering, bioadhesive gel. Amaral E; Faúndes A; Zaneveld L; Waller D; Garg S Contraception; 1999 Dec; 60(6):361-6. PubMed ID: 10715372 [TBL] [Abstract][Full Text] [Related]
7. Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection. Van Damme L; Niruthisard S; Atisook R; Boer K; Dally L; Laga M; Lange JM; Karam M; Perriens JH AIDS; 1998 Mar; 12(4):433-7. PubMed ID: 9520174 [TBL] [Abstract][Full Text] [Related]
8. Nonoxynol-9 100 mg gel: multi-site safety study from sub-Saharan Africa. Hoffman IF; Taha TE; Padian NS; Kelly CW; Welch JD; Martinson FE; Kumwenda NI; Rosenberg ZF; Chilongozi DA; Brown JM; Chirenje M; Richardson BA AIDS; 2004 Nov; 18(16):2191-5. PubMed ID: 15577653 [TBL] [Abstract][Full Text] [Related]
9. Effects of multiple applications of benzalkonium chloride and nonoxynol 9 on the vaginal epithelium in the pigtailed macaque (Macaca nemestrina). Patton DL; Kidder GG; Sweeney YC; Rabe LK; Hillier SL Am J Obstet Gynecol; 1999 May; 180(5):1080-7. PubMed ID: 10329859 [TBL] [Abstract][Full Text] [Related]
10. A randomized Phase I vaginal safety study of three concentrations of C31G vs. Extra Strength Gynol II. Mauck CK; Weiner DH; Creinin MD; Barnhart KT; Callahan MM; Bax R Contraception; 2004 Sep; 70(3):233-40. PubMed ID: 15325893 [TBL] [Abstract][Full Text] [Related]
11. A phase I comparative study of contraceptive vaginal films containing benzalkonium chloride and nonoxynol-9. Postcoital testing and colposcopy. Mauck CK; Baker JM; Barr SP; Abercrombie TJ; Archer DF Contraception; 1997 Aug; 56(2):89-96. PubMed ID: 9315417 [TBL] [Abstract][Full Text] [Related]
12. Phase 1 trial of nonoxynol-9 film among sex workers in South Africa. Rustomjee R; Abdool Karim Q; Abdool Karim SS; Laga M; Stein Z AIDS; 1999 Aug; 13(12):1511-5. PubMed ID: 10465075 [TBL] [Abstract][Full Text] [Related]
13. A dosing study of nonoxynol-9 and genital irritation. Roddy RE; Cordero M; Cordero C; Fortney JA Int J STD AIDS; 1993; 4(3):165-70. PubMed ID: 8391856 [TBL] [Abstract][Full Text] [Related]
14. Phase I safety & preliminary acceptability of nonoxynol-9 vaginal pessary as a vaginal microbicide in low risk women in Pune, India. Joshi S; Joglekar N; Ghate M; Unni J; Risbud A; Bentley M; Shepherd M; Bollinger R; Mehendale S Indian J Med Res; 2003 Apr; 117():152-7. PubMed ID: 14604303 [TBL] [Abstract][Full Text] [Related]
15. Mucosal integrity and inflammatory markers in the female lower genital tract as potential screening tools for vaginal microbicides. Su HI; Schreiber CA; Fay C; Parry S; Elovitz MA; Zhang J; Shaunik A; Barnhart K Contraception; 2011 Nov; 84(5):525-32. PubMed ID: 22018129 [TBL] [Abstract][Full Text] [Related]
16. Colposcopic evaluation of a vaginal gel formulation of iota-carrageenan. Elias CJ; Coggins C; Alvarez F; Brache V; Fraser IS; Lacarra M; Lähteenmäki P; Massai R; Mishell DR; Phillips DM; Salvatierra AM Contraception; 1997 Dec; 56(6):387-9. PubMed ID: 9494773 [TBL] [Abstract][Full Text] [Related]
18. Optical coherence tomography compared with colposcopy for assessment of vaginal epithelial damage: a randomized controlled trial. Vincent KL; Stanberry LR; Moench TR; Breitkopf CR; Loza ML; Wei J; Grady J; Paull J; Motamedi M; Rosenthal SL Obstet Gynecol; 2011 Dec; 118(6):1354-1361. PubMed ID: 22105265 [TBL] [Abstract][Full Text] [Related]
19. The effects of frequent nonoxynol-9 use on the vaginal and cervical mucosa. Niruthisard S; Roddy RE; Chutivongse S Sex Transm Dis; 1991; 18(3):176-9. PubMed ID: 1658953 [TBL] [Abstract][Full Text] [Related]